Visceral adipose tissue comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2026-07-12. Where a claim depends on a specific study, the study is described rather than over-claimed.
Signaling begins at the GHRH receptor, a class B G protein-coupled receptor displayed on somatotroph cells of the anterior pituitary. Receptor occupancy activates Gs proteins, which raise adenylyl cyclase activity and intracellular cyclic AMP, in turn driving protein kinase A dependent pathways. The downstream output is synthesis and pulsatile secretion of growth hormone into the bloodstream. Hepatic tissue and peripheral sites respond by increasing insulin-like growth factor 1 production. Somatostatin and IGF-1 itself supply negative feedback that caps the size and duration of each secretory burst.
Metabolic interest in this compound centers on fat distribution rather than on hormone levels alone. Imaging trials in adults with excess abdominal fat report reductions in visceral adipose tissue, while subcutaneous depots change comparatively little. Growth hormone and IGF-1 are presumed to carry the effect, but the separate contribution of each is not firmly established. Whether these changes persist after treatment stops, and whether they alter longer-term health outcomes, remain open questions that published work does not answer consistently.
Tesamorelin is a synthetic peptide of forty-four amino acids whose sequence reproduces human growth hormone-releasing hormone. Its distinguishing feature sits at the amino terminus, where a trans-3-hexenoyl group replaces the free amine. That acylation slows cleavage by dipeptidyl peptidase IV, an enzyme that otherwise removes the first two residues and inactivates the natural hormone quickly. The modified peptide therefore persists longer in circulation while keeping the same receptor target. It is handled as a lyophilized solid and dissolved shortly before use.
Clinical study of tesamorelin has centered on adults with HIV-associated lipodystrophy, a condition in which abdominal fat accumulates while peripheral fat is lost. In controlled trials, treated participants showed reductions in visceral adipose tissue measured by imaging, alongside modest shifts in some lipid values. Effects on subcutaneous fat were smaller and less consistent across studies. Whether these changes translate into fewer cardiovascular events remains an open question, because the trials were not designed or powered to answer it.
Tesamorelin is a synthetic peptide that acts as an analog of growth hormone-releasing hormone, a natural hypothalamic signal. Its sequence corresponds to the forty-four amino acid form of the human hormone, with a small acyl group attached near the amino terminus. That modification slows enzymatic breakdown and extends the time the peptide remains active in circulation. The compound was developed as a pharmacological way to raise endogenous growth hormone output rather than supplying the hormone directly.
After injection, the peptide binds receptors on somatotroph cells in the anterior pituitary. Receptor activation raises intracellular cyclic AMP and triggers release of stored growth hormone into the bloodstream. Because the compound works through the body's own regulatory system, growth hormone pulses retain much of their normal feedback control. Repeated administration also raises insulin-like growth factor 1, a hormone produced mainly in the liver. Investigators treat that rise as a marker that the pituitary axis has been engaged.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic 44-residue peptide | GHRH analog backbone |
| Approximate molecular mass | 5136 Da | Varies with counterion and hydration state |
| N-terminal group | trans-3-hexenoyl | Increases resistance to dipeptidyl peptidase IV |
| Primary receptor | GHRH receptor (GHRHR) | Class B G protein-coupled receptor on somatotrophs |
| Principal mediator | IGF-1 | Rises indirectly after growth hormone release |
Tesamorelin binds to growth hormone-releasing hormone receptors on the surface of pituitary somatotroph cells. This binding activates adenylate cyclase, raising intracellular cyclic AMP levels and triggering the release of growth hormone into circulation. The elevated growth hormone then stimulates hepatic production of insulin-like growth factor 1. Because the effect is mediated through the endogenous axis, secretion remains subject to feedback regulation. This distinguishes it from direct growth hormone administration, which bypasses pituitary control entirely.
Clinical investigation has focused on HIV-associated lipodystrophy, a condition in which antiretroviral therapy contributes to abnormal fat distribution. Excess visceral adipose tissue accumulates in the abdomen while peripheral fat may be lost. Tesamorelin was evaluated for reducing this visceral fat depot, with trials measuring changes in abdominal fat by imaging rather than by body weight alone. The rationale rests on the known lipolytic effects of growth hormone. Effects on visceral fat are documented, while long-term outcomes regarding cardiovascular risk remain less clearly established.
Several related peptides act on the same receptor, including sermorelin, a shorter GHRH fragment, and modified analogs such as CJC-1295 and modified GRF(1-29) that are common in research settings rather than approved products. Tesamorelin differs from growth hormone itself in that it acts upstream, prompting the pituitary to release the hormone through physiological signaling rather than supplying it directly. Terminology in the literature distinguishes GHRH analogs, growth hormone secretagogues, and recombinant growth hormone, although popular discussion often blurs these categories together. Precise naming matters when comparing study results.
Tesamorelin is a synthetic peptide of 44 amino acids that reproduces the sequence of human growth hormone-releasing hormone (GHRH) and carries a trans-3-hexenoyl group on its N-terminal tyrosine. That small fatty-acid modification blocks cleavage by dipeptidyl peptidase-4, the enzyme that rapidly degrades native GHRH in plasma. The result is a molecule with a longer circulating half-life than the natural hormone while retaining the same receptor target. It is supplied as a lyophilized powder for reconstitution and belongs to the broader class of GHRH analogs studied for effects on pituitary growth hormone secretion.
Regulatory approval in the United States came in 2010, when the Food and Drug Administration cleared the peptide for the reduction of excess abdominal fat in adults with HIV infection and associated lipodystrophy. The decision rested mainly on two randomized phase 3 trials that enrolled roughly eight hundred patients and ran for twenty-six weeks. Participants receiving active drug showed substantially greater declines in visceral adipose tissue than those receiving placebo, while total body weight changed comparatively little. A reformulated presentation was later approved, and the product has remained a niche therapy rather than a general weight-loss agent.
Tesamorelin occupies a narrow position among agents that act on the growth hormone axis. Unlike growth hormone itself, which is given as replacement, it stimulates the pituitary to release the hormone in pulses, so the downstream increase in insulin-like growth factor 1 depends on intact somatotroph function. Other peptides in the same family include shorter GHRH fragments and synthetic secretagogues with different stability profiles. Several points remain unresolved, including whether the reduction in visceral fat translates into fewer cardiovascular events, what happens to metabolic markers after long-term use, and how the drug compares with lifestyle or surgical approaches.
Connective tissues are made up of cells separated by non-living material, which is called an extracellular matrix. This matrix can be liquid or rigid. For example, blood contains plasma as its matrix and bone's matrix is rigid. Connective tissue gives shape to organs and holds them in place. Blood, bone, tendon, ligament, adipose, and areolar tissues are examples of connective tissues. One method of classifying connective tissues is to divide them into three types: fibrous connective tissue, skeletal connective tissue, and fluid connective tissue.
=== Pharmacology === Cannabinoids are administered via smoking, vaporizing, oral ingestion, transdermal patch, intravenous injection, sublingual absorption, or rectal suppository. Most are metabolized in the liver by cytochrome P450 enzymes, mainly CYP 2C9. Inhibiting CYP 2C9 can extend intoxication. Δ9-THC is metabolized to 11-hydroxy-Δ9-THC and then 9-carboxy-THC, detectable in the body for weeks due to their lipophilic nature and storage in fat. The entourage effect suggests that terpenes modulate cannabinoid effects.
The United States' 4 million miles (6.4 million kilometers) of road network, owned almost entirely by state and local governments, is the longest in the world. The extensive Interstate Highway System that connects all major U.S. cities is funded mostly by the federal government but maintained by state departments of transportation. The system is further extended by state highways and some private toll roads. The U.S. ranks among the ten countries with the highest vehicle ownership per capita, with 850 vehicles per 1,000 residents in 2022. A 2024 survey reported 58.3% of households with two or more vehicles, and 21.9% with three or more. According to the 2022 American Community Survey, 68.7% of U.S. workers aged 16 and older drove alone to work, 2.9% walked or cycled, and 3.1% used public transportation. Public transportation in the United States is well developed in the largest urban areas, notably New York City, Washington, D.C., Boston, Philadelphia, Chicago, and the San Francisco Bay Area; otherwise, coverage is generally less extensive than in most other developed countries. The U.S. also has many relatively car-dependent localities. Long-distance intercity travel is provided primarily by airlines, but travel by rail is more common along the Northeast Corridor, where the only high-speed rail in the U.S. that meets international standards operates. Amtrak, the country's government-sponsored national passenger rail company, has a relatively sparse network compared to that of Western European countries.
A pulsed laser system facilitates the efficient coupling of a time-of-flight mass spectrometer (TOF-MS) to the resonance ionization set-up due to the instrument's abundance sensitivity. This is because TOF systems can produce an abundance sensitivity of up to 104 whereas magnetic mass spectrometers can only achieve up to 102. The total selectivity in a RIS process is a combination of the sensitivities in the various resonance transitions for multiple step-wise excitations. The probability of an atom to come in contact with the resonance of another atom is about 10−5. The addition of a mass spectrometer increases this figure by a factor of 106 such that the total elemental selectivity surpasses or at least compares to that of tandem mass spectrometry (MS/MS), the most selective technique available.
The XM913 is an experimental American chain gun produced at Picatinny Arsenal. The cannon is a larger and more modern version of the 35 mm Bushmaster III chain gun, which itself is a larger version of the 25 mm M242 Bushmaster cannon. Although its shells, 50 x 228 mm, are twice the diameter of the 25×137mm cartridge of the M242, the 50mm cannon is not much longer than the smaller weapon. The overall lengths of the 25mm cannon and 50mm cannon are 105.2 inches (267 cm) and 117.7 inches (299 cm), respectively; while the portion of the gun that intrudes into the turret are 30.0 inches (76 cm) and 40.1 inches (102 cm), respectively. The XM913 has been selected as the primary weapon on the US Army's new Next Generation Combat Vehicle, the XM30 MICV.
Sources: en.wikipedia.org
Since the turn of the millennium, the Russian Armed Forces have been issued the Individual Food Rations (Russian: Индивидуальный рацион питания/ИРП, romanized: Individual'nyi Ratsion Pitaniya (IRP)), a new self-contained ration, containing the whole daily food intake for an individual soldier in the field. However, in its most frequent form it is not dietary complete, and is intended only as a stop-gap measure to be issued until the normal supply lines (with their field kitchens) are established and the hot food delivery started, to be issued for no more than six days straight. The Ministry of Defence does not strictly prescribe the contents of the ration, only some basic packaging and inventory requirements, so every producer issues their own version. Most commonly it is packaged into a sturdy plastic blister box (nicknamed "The Frog" in the field for its olive-green color), or plastic-sealed cardboard box that contains five to six entrees in laminated foil cans or retort pouches, four to six pack of crackers or preserved bread, two to three dessert items in form of a spread or fruit bar, four beverage concentrate pouches, some seasonings (salt, pepper, sugar, ketchup), and various sundry items like sanitizing wipes/paper towels, spoons, can opener, four hexamine fuel tablets, folding heater, matches and water purifier tablets.
In 1877, the colonial authorities created the Quthing District and appointed Hamilton Hope as the magistrate to oversee the Baputhi, a move opposed by Moorosi. In April 1878, the colonial authorities dispatched 80 African policemen and 700 Basuto warriors to apprehend Moorosi's son Tota; the dispute was resolved peacefully. Hope was replaced by the more experienced John Austen, who was likewise distrusted by Moorosi. Tota was finally imprisoned after being implicated in horse theft, his subsequent escape from captivity and Moorosi's refusal to hand him over impelled Cape Colony prime minister Sir Gordon Sprigg to authorize the forced disarmament of the Baphuthi. Austen ordered Letsie I to assist the Cape in the campaign, threatening to hand over parts of Quthing to white settlers and establish garrisons of colonial troops in Basutoland. Letsie I reluctantly agreed. The fighting lasted for several months, as the Baphuthi had entrenched themselves in the isolated Mount Moorosi. On 28 November 1879, the colonial troops managed to reach the summit with ladders, killing Moorosi in the final confrontation. Moorosi's severed head was paraded in King William's Town, an act that shocked Letsie I.
selfish genetic element Also selfish DNA or parasitic DNA. Any genetic material (e.g. a gene or any other DNA sequence) which can enhance its own replication and/or transmission into subsequent generations at the expense of other genes in the genome, even if doing so has no positive effect or even a net negative effect on the fitness of the genome as a whole. Selfish elements usually work by producing self-acting gene products which repeatedly copy and paste their own coding sequences into other parts of the genome, independently of normal DNA replication (as with transposable elements); by facilitating the uneven swapping of chromosome segments during genetic recombination events (as with unequal crossing over); or by disrupting the normally equal redistribution of replicated material during mitosis or meiosis such that the probability that the selfish element is present in a given daughter cell is greater than the normal 50 percent (as with gene drives).
Carbon nanotubes are the strongest and stiffest materials yet discovered in terms of tensile strength and elastic modulus. This strength results from the covalent sp2 bonds formed between the individual carbon atoms. In 2000, a multiwalled carbon nanotube was tested to have a tensile strength of 63 GPa (9,100,000 psi). (For illustration, this translates into the ability to endure tension of a weight equivalent to 6,422 kilograms-force (62,980 N; 14,160 lbf) on a cable with cross-section of 1 mm2 (0.0016 sq in)). Further studies, such as one conducted in 2008, revealed that individual CNT shells have strengths of up to ≈100 GPa (15,000,000 psi), which is in agreement with quantum/atomistic models. Because carbon nanotubes have a low density for a solid of 1.3 to 1.4 g/cm3, its specific strength of up to 48,000 kN·m/kg is the best of known materials, compared to high-carbon steel's 154 kN·m/kg. Although the strength of individual CNT shells is extremely high, weak shear interactions between adjacent shells and tubes lead to significant reduction in the effective strength of multiwalled carbon nanotubes and carbon nanotube bundles down to only a few GPa. This limitation has been recently addressed by applying high-energy electron irradiation, which crosslinks inner shells and tubes, and effectively increases the strength of these materials to ≈60 GPa for multiwalled carbon nanotubes and ≈17 GPa for double-walled carbon nanotube bundles. CNTs are not nearly as strong under compression.
Sources: en.wikipedia.org
The amino acid sequence matches human growth hormone-releasing hormone, but the amino terminus carries a trans-3-hexenoyl group instead of a free amine. That single structural change chiefly affects enzymatic stability rather than receptor selectivity.
Growth hormone released from the pituitary stimulates IGF-1 production in the liver and other tissues, so circulating IGF-1 generally rises during exposure. The size of the rise varies between individuals and depends on baseline hormonal status and other concurrent factors.
Reported imaging studies focus on visceral adipose tissue, where reductions are more consistently observed across trials. Subcutaneous depots show smaller and less reproducible changes, so the two compartments should not be treated as equivalent.
It is a laboratory-made peptide that mimics growth hormone-releasing hormone. It prompts the pituitary gland to release growth hormone and has been studied mainly in adults with HIV-associated lipodystrophy.